Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

G1 Therapeutics, Inc. (GTHX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues   [+]51.331.545.30.00.00.00.00.5
            Revenue growth  63.0%-30.5%    -100.0% 
Cost of goods sold  3.72.00.00.00.00.00.00.0
Gross profit  47.629.545.30.00.00.00.00.5
            Gross margin  92.7%93.6%100.0%    100.0%
Selling, general and administrative   [+]100.495.768.540.018.67.15.23.2
Research and development  83.376.273.389.070.753.925.212.7
EBITDA   [+]-135.6-142.0-95.9-128.7-89.1-60.9-30.3-15.4
            EBITDA margin  -264.4%-451.1%-211.8%    -2946.7%
Depreciation and amortization  0.50.50.60.40.20.10.10.0
EBIT   [+]-136.2-142.5-96.5-129.0-89.3-61.0-30.4-15.4
            EBIT margin  -265.4%-452.6%-213.0%    -2954.8%
Interest expense, net   [+]9.74.60.8-6.6-4.0   
Other income (expense), net   [+]0.0-0.3-0.50.0 0.80.1-4.8
Pre-tax income  -145.9-147.4-97.8-122.4-85.3-60.1-30.3-20.3
Income taxes  1.70.91.40.00.00.00.00.0
            Tax rate     0.0%0.0%0.0%0.0%0.0%
Net income  -147.6-148.4-99.3-122.4-85.3-64.9-34.7-21.7
            Net margin  -287.6%-471.3%-219.2%    -4155.2%
   
Basic EPS   [+]($3.38)($3.54)($2.62)($3.27)($2.56)($3.57)($23.33)($16.13)
Diluted EPS   [+]($3.38)($3.54)($2.62)($3.27)($2.56)($3.57)($23.33)($16.13)
   
Shares outstanding (basic)   [+]43.641.937.937.533.318.21.51.3
Shares outstanding (diluted)   [+]43.641.937.937.533.318.21.51.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy